pirfenidone has been researched along with Interstitial Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhaji, AA; Bi, L; Hou, G; Huang, Y; Li, J; Liu, B; Yang, X; Yang, Y; Zhai, P; Zhang, Q | 1 |
| Chen, JF; Chen, PS; Liu, BC; Liu, H; Lv, LL; Ni, HF; Tang, RN; Zhang, AH; Zhang, MH | 1 |
2 other study(ies) available for pirfenidone and Interstitial Nephritis
| Article | Year |
|---|---|
Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Epithelial-Mesenchymal Transition; Extracellular Matrix; Kidney Tubules; Male; MicroRNAs; Nephritis, Interstitial; Pyridones; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta1 | 2022 |
Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Fibrosis; Humans; Kidney Tubules, Proximal; Male; Mitochondria; Nephrectomy; Nephritis, Interstitial; Pyridones; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2013 |